| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233339 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
These data on long-term survival continue to support the use of I-125 monotherapy for prostate cancer in low-risk patients and, in particular, demonstrate its efficacy in intermediate-risk patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Karel A. M.D., Jan J. M.D., Ph.D., Joep G.H. M.D., Marinus A. Ph.D., Ina M. M.D., Ph.D., Steven J. M.D., Marco M.D., Ph.D.,